Hamamatsu Pharma Research, Inc.

Drug Discovery > Pharmacology

Hamamatsu Pharma Research, Inc. is dedicated to preclinical efficacy evaluation of novel therapeutics in non-human primate disease models, including pain (chemotherapy-induced neuropathic pain & osteoarthritis) and cerebral ischemia/stroke.

Contact

Ikuo Hayashi COO Phone: 858-535-4819
Hiroyuki Takamatsu CEO Phone: +81-53-543-4543
http://www.hpharmausa.com
4660 La Jolla Village Drive 500 San Diego, CA 92122